These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8896541)

  • 1. Efficacy of high-titer live attenuated varicella vaccine in healthy young children.
    Varis T; Vesikari T
    J Infect Dis; 1996 Nov; 174 Suppl 3():S330-4. PubMed ID: 8896541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial.
    Hao B; Chen Z; Zeng G; Huang L; Luan C; Xie Z; Chen J; Bao M; Tian X; Xu B; Wang Y; Wu J; Xia S; Yuan L; Huang J
    Clin Microbiol Infect; 2019 Aug; 25(8):1026-1031. PubMed ID: 30616012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
    Ramkissoon A; Coovadia HM; Jugnundan P; Haffejee IE; Meurice F; Vandevoorde D
    S Afr Med J; 1995 Dec; 85(12):1295-8. PubMed ID: 8600589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children.
    Meurice F; De Bouver JL; Vandevoorde D; Woods S; Bogaerts H
    J Infect Dis; 1996 Nov; 174 Suppl 3():S324-9. PubMed ID: 8896540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children.
    Tan AY; Connett CJ; Connett GJ; Quek SC; Yap HK; Meurice F; Lee BW
    Eur J Pediatr; 1996 Aug; 155(8):706-11. PubMed ID: 8839730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children.
    Lau YL; Vessey SJ; Chan IS; Lee TL; Huang LM; Lee CY; Lin TY; Lee BW; Kwan K; Kasim SM; Chan CY; Kaplan KM; Distefano DJ; Harmon AL; Golie A; Hartzel J; Xu J; Li S; Matthews H; Sadoff JC; Shaw A
    Vaccine; 2002 Jul; 20(23-24):2942-9. PubMed ID: 12126906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting--a pilot study.
    Mor M; Harel L; Kahan E; Amir J
    Vaccine; 2004 Dec; 23(3):325-8. PubMed ID: 15530676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
    Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
    Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
    Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
    Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP
    N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine.
    Watson B; Gupta R; Randall T; Starr S
    J Infect Dis; 1994 Jan; 169(1):197-9. PubMed ID: 8277182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a live attenuated varicella vaccine in 15- to 18-month-old healthy children.
    Lu MY; Huang LM; Lee CY; Lee PI; Chiu HH; Tsai HY
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1998; 39(1):38-42. PubMed ID: 9553291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postexposure varicella vaccination in nine-month-old children.
    Kanra G; Ceyhan M; Ozmert E
    Pediatr Infect Dis J; 2000 Oct; 19(10):1029-30. PubMed ID: 11055616
    [No Abstract]   [Full Text] [Related]  

  • 16. Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine.
    Sperber SJ; Smith BV; Hayden FG
    Antiviral Res; 1992 Mar; 17(3):213-22. PubMed ID: 1314536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial.
    Huang L; Chen Z; Hu Y; Xie Z; Qiu P; Zhu L; Bao M; Quan Y; Zeng J; Wang Y; Cui X; Yuan L; Xia S; Meng F
    Hum Vaccin Immunother; 2019; 15(4):822-827. PubMed ID: 30481106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
    Gershon AA; Steinberg SP
    J Infect Dis; 1990 Apr; 161(4):661-6. PubMed ID: 2156941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.